Retrovirus-mediated transfer of a suicide gene into lens epithelial cells in vitro and in an experimental model of posterior capsule opacification

被引:39
作者
Couderc, BC
de Neuville, S
Douin-Echinard, V
Serres, B
Manenti, S
Darbon, JM
Malecaze, F
机构
[1] CHU Purpan, CJF Inserm 9510, F-31059 Toulouse, France
[2] Inst Claudius Regaud, EA UPRES 2048, Toulouse, France
[3] Fac Pharmaceut Sci, Toulouse, France
关键词
lens epithelial cells; ganciclovir; proliferative capsule opacification; retroviral vector; suicide gene;
D O I
10.1076/ceyr.19.6.472.5284
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose. The most common complication of cataract surgery is the development of posterior capsule opacification (PCO). Hyperplasia of the lens epithelium is one of the main cellular events following phacoemulsification and was found to be an important feature contributing to opacification of the posterior capsule. We investigated the feasibility of killing the residual lens epithelial cells by retroviral-mediated transfer of the herpes simplex virus-thymidine kinase (HSV-tk) gene, a well-studied suicide gene, into rabbit lens epithelial cells followed by ganciclovir (GCV) treatment. Methods. The capacity of retroviral vectors to transfer genes into rabbit lens epithelial cells was determined either in vitro (culture of rabbit lens epithelial cells) or in ville (experimental model of PCO in rabbits) using cDNA encoding the beta-galactosidase (LacZ) reporter gene. To evaluate the efficiency of suicide gene therapy (infection with retroviral vectors encoding the HSV-tk gene followed by GCV treatment) we determined the sensitivity of HSV-tk infected lens epithelial cells to different concentrations of GCV in vitro. Then, in an experimental model of PCO, rabbits were treated with HSV-tk retroviral vectors at the end of the surgery and they received repeated intracameral and intravitreal injections of GCV at the concentration determined by the in vitro experiments. Results. Infection efficiency using LacZ retroviral vectors was about 29% in vitro and 10% in vivo. After infection of the HSV-tk cDNA in vitro, the cell killing effect of GCV was evaluated. A significant enhancement (four- to five-fold) of the cell sensitivity to GCV was shown in FLY-DFGtk as compared with mock infected (P < 0.01) cells even without selection of the HSV-tk positive cells. The GCV concentration leading to 50% reduction in cell number (IC50) was 50 mu g/ml. rn vivo infection with a HSV-tk vector led to the tk gene transfer into lens epithelial cells. Despite this local HSV-tk gene expression, we could not prevent capsule opacification. Conclusions. Lens epithelial cells were successfully infected both in vitro and in vivo by beta-galactosidase and HSV-tk genes via retroviral vectors. in vitro infected lens epithelial cells displayed a strong sensitivity to GCV treatment. In vivo, we could not prevent capsule opacification in the rabbit model, very likely due to the limited level of the HSV-tk gene expression. However, our results suggest that virus-mediated suicide gene therapy might be a feasible treatment strategy to prevent capsule opacification with a more powerful vector.
引用
收藏
页码:472 / 482
页数:11
相关论文
共 50 条
[1]  
ABRAHAM NG, 1995, INVEST OPHTH VIS SCI, V36, P2202
[2]   POSTERIOR CAPSULE OPACIFICATION [J].
APPLE, DJ ;
SOLOMON, KD ;
TETZ, MR ;
ASSIA, EI ;
HOLLAND, EY ;
LEGLER, UFC ;
TSAI, JC ;
CASTANEDA, VE ;
HOGGATT, JP ;
KOSTICK, AMP .
SURVEY OF OPHTHALMOLOGY, 1992, 37 (02) :73-116
[3]  
BEHARCOHEN FF, 1995, INVEST OPHTH VIS SCI, V36, P2425
[4]  
BENNETT J, 1994, INVEST OPHTH VIS SCI, V35, P2535
[5]   Differential ganciclovir-mediated cytotoxicity and bystander killing in human colon carcinoma cell lines expressing herpes simplex virus thymidine kinase [J].
Boucher, PD ;
Ruch, RJ ;
Shewach, DS .
HUMAN GENE THERAPY, 1998, 9 (06) :801-814
[6]  
BOVIATSIS EJ, 1994, CANCER RES, V54, P5745
[7]  
BUDENZ DL, 1995, INVEST OPHTH VIS SCI, V36, P2211
[8]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[9]   HIGH-TITER PACKAGING CELLS PRODUCING RECOMBINANT RETROVIRUSES RESISTANT TO HUMAN SERUM [J].
COSSET, FL ;
TAKEUCHI, Y ;
BATTINI, JL ;
WEISS, RA ;
COLLINS, MKL .
JOURNAL OF VIROLOGY, 1995, 69 (12) :7430-7436
[10]   INVIVO GENE-TRANSFER WITH RETROVIRAL VECTOR PRODUCER CELLS FOR TREATMENT OF EXPERIMENTAL BRAIN-TUMORS [J].
CULVER, KW ;
RAM, Z ;
WALLBRIDGE, S ;
ISHII, H ;
OLDFIELD, EH ;
BLAESE, RM .
SCIENCE, 1992, 256 (5063) :1550-1552